Literature DB >> 32719354

Effects of high-intensity interval training compared with resistance training in prostate cancer patients undergoing radiotherapy: a randomized controlled trial.

Gilles Caty1,2,3, Gregory Reychler4,5,6,7, Elise Piraux8,9,10, Laurette Renard11, David Vancraeynest12,13, Bertrand Tombal14, Xavier Geets11,15.   

Abstract

BACKGROUND: Exercise training has shown beneficial effects in the management of radiotherapy-related side effects in prostate cancer (PCa) patients undergoing radiation therapy (RT). However, the optimal modality of the exercise programs have not been yet determined. The aim of this randomized controlled trial was to investigate the effects of high-intensity interval training (HIIT) and resistance training (RES) compared to usual care (UC) on cancer-treatment-related fatigue (CTRF) (primary outcome), quality of life, depression, daytime sleepiness, insomnia, sleep quality, functional exercise capacity and executive function in PCa patients during RT.
METHODS: PCa patients undergoing RT with or without ADT were randomized in HIIT, RES or UC. Both exercise programs included three sessions per week during 5-8 weeks. HIIT consisted of 8-15 × 60 s intervals (≥85% maximal heart rate). RES was performed with 1-3 sets of 8-12 repetitions for each large muscle groups. The primary outcome was changed in CTRF measured with the Functional Assessment of Chronic Illness Therapy-Fatigue.
RESULTS: Seventy-two subjects (69.1 ± 8.2 years) completed the study. No exercise-related adverse events occurred. HIIT (p = 0.012) and RES (p = 0.039) training attenuated increases in CTRF compared to UC. Functional exercise capacity, evaluated by the 6-min walk test, increased after HIIT (p = 0 = 0.43) and RES (p = 0.041) compared to UC (+0.1%). No other secondary variables were different between groups.
CONCLUSIONS: Both intervention groups displayed beneficial effects on CTRF and functional exercise capacity in PCa patients undergoing RT. In addition, HIIT and RES are both safe with an excellent attendance rate to the exercise sessions.

Entities:  

Year:  2020        PMID: 32719354     DOI: 10.1038/s41391-020-0259-6

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  37 in total

1.  Prospective evaluation of the prevalence and severity of fatigue in patients with prostate cancer undergoing radical external beam radiotherapy and neoadjuvant hormone therapy.

Authors:  Pauline T Truong; Eric Berthelet; Junella C Lee; Ross Petersen; Jan T W Lim; Catherine A Gaul; Howard Pai; Paul Blood; Charles M Ludgate
Journal:  Can J Urol       Date:  2006-06       Impact factor: 1.344

2.  Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  C Parker; S Gillessen; A Heidenreich; A Horwich
Journal:  Ann Oncol       Date:  2015-07-22       Impact factor: 32.976

Review 3.  Measuring psychosocial functioning in the radiation oncology clinic: a systematic review.

Authors:  Clayton B Hess; Allen M Chen
Journal:  Psychooncology       Date:  2014-05-21       Impact factor: 3.894

4.  The impact of radiotherapy on symptoms, anxiety and QoL in patients with cancer.

Authors:  Penelope Gogou; Eleni Tsilika; Efi Parpa; Ioannis Kouvaris; Dimitrios Damigos; Myrsini Balafouta; Venetsanos Maureas; Kyriaki Mystakidou
Journal:  Anticancer Res       Date:  2015-03       Impact factor: 2.480

5.  Association of Fatigue Intensification with Cognitive Impairment during Radiation Therapy for Prostate Cancer.

Authors:  Li Rebekah Feng; Alexandra Espina; Leorey N Saligan
Journal:  Oncology       Date:  2018-03-07       Impact factor: 2.935

6.  Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.

Authors:  A L Potosky; J Legler; P C Albertsen; J L Stanford; F D Gilliland; A S Hamilton; J W Eley; R A Stephenson; L C Harlan
Journal:  J Natl Cancer Inst       Date:  2000-10-04       Impact factor: 13.506

7.  The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer.

Authors:  C G Bacon; E Giovannucci; M Testa; I Kawachi
Journal:  J Urol       Date:  2001-11       Impact factor: 7.450

8.  Clinically relevant fatigue in recurrence-free prostate cancer survivors.

Authors:  D J Storey; D B McLaren; M A Atkinson; I Butcher; S Liggatt; R O'Dea; J F Smyth; M Sharpe
Journal:  Ann Oncol       Date:  2011-03-24       Impact factor: 32.976

Review 9.  Sleep-wake disturbances in people with cancer part I: an overview of sleep, sleep regulation, and effects of disease and treatment.

Authors:  Catherine Vena; Kathy Parker; Mary Cunningham; Jane Clark; Susany McMillan
Journal:  Oncol Nurs Forum       Date:  2004-07-13       Impact factor: 2.172

10.  A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma.

Authors:  Phyllis M Windsor; Kathleen F Nicol; Joan Potter
Journal:  Cancer       Date:  2004-08-01       Impact factor: 6.860

View more
  3 in total

Review 1.  Effect of high-intensity interval training on aerobic capacity and fatigue among patients with prostate cancer: a meta-analysis.

Authors:  Ming Chang; Junguo Wang; Hairul A Hashim; Shihao Xie; Adam A Malik
Journal:  World J Surg Oncol       Date:  2022-10-19       Impact factor: 3.253

Review 2.  Skeletal Muscle-Adipose Tissue-Tumor Axis: Molecular Mechanisms Linking Exercise Training in Prostate Cancer.

Authors:  Sílvia Rocha-Rodrigues; Andreia Matos; José Afonso; Miguel Mendes-Ferreira; Eduardo Abade; Eduardo Teixeira; Bruno Silva; Eugenia Murawska-Ciałowicz; Maria José Oliveira; Ricardo Ribeiro
Journal:  Int J Mol Sci       Date:  2021-04-25       Impact factor: 5.923

Review 3.  Effectiveness of Resistance Training on Fatigue in Patients Undergoing Cancer Treatment: A Meta-Analysis of Randomized Clinical Trials.

Authors:  Lily Berríos Contreras; Rodrigo Cuevas Cid; Luz Alejandra Lorca; Ivana Leão Ribeiro
Journal:  Int J Breast Cancer       Date:  2022-08-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.